
Ahead of the Union Budget 2026, India's healthcare, pharmaceutical, and insurance sectors are urging for increased focus on preventive care, innovation, and improved patient access. Key demands include greater public spending on early diagnosis and referral systems, faster access to new treatments, and a clear policy environment to reduce out-of-pocket expenses. The pharmaceutical industry is specifically seeking R&D incentives, GST rationalization, and support for domestic manufacturing to foster innovation and self-reliance.
Select a news story to see related coverage from other media outlets.